Tuberculosis

BWH launches research and training initiative for MDR-TB Siberia

Published in TB and Outbreaks Week, December 9th, 2003

Eli Lilly and Co. (LLY) joined Brigham and Women's Hospital (BWH), an affiliate of Harvard Medical School, in announcing the launch of a new research and training initiative for multidrug resistant tuberculosis (MDR-TB) in Tomsk, Siberia, one of the world's hotspots for this deadly public health threat.

As a part of the initiative, healthcare workers from Russia and other countries of the former Soviet Union with high burdens of MDR-TB will be trained, while research data obtained will be used globally to improve and potentially develop new treatments for the disease.

"One of our primary goals for the Lilly MDR-TB global partnership is to effectively...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2003-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry